Eli Lilly and Company - Income Before Tax

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Income-Before-Tax" stands at 22.50 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Eli Lilly and Company's third quarter result of 7.23 Billion USD for the item "Income Before Tax" represents an increase of 6.73 percent compared to it's second quarter result.

Also, Eli Lilly and Company's third quarter result of 7.23 Billion USD for the item "Income Before Tax" represents an increase of 355.33 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Eli Lilly and Company's third quarter result of 22.50 Billion USD for the item "Income Before Tax" represents an increase of 33.48 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 121.70 percent compared to the value the year prior.
The 1 year change in percent is 121.70.
The 3 year change in percent is 243.57.
The 5 year change in percent is 250.31.
The 10 year change in percent is 687.11.

The Serie's long term average value is 5.86 Billion United States Dollars. It's latest available value, on 09/30/2025, is 283.83 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2017, to it's latest available value, on 09/30/2025, is +924.10%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.